📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine (2021)

First Author: Kawuma A

Attributed to: Liverpool COVID-19 Drug Interactions (www.covid19-druginteractions.org) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkab022

PubMed Identifier: 33550391

Publication URI: http://europepmc.org/abstract/MED/33550391

Type: Journal Article/Review

Parent Publication: Journal of Antimicrobial Chemotherapy

Issue: 5

ISSN: 0305-7453